According to Minerva Neurosciences 's latest financial reports and stock price the company's current Operating Margin is 4.48%. At the end of 2020 the company had an Operating Margin of 4.49%.
Year | Operating Margin | Change |
---|---|---|
2020 | 4.49% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Incyte INCY | 15.90% | 254.91% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | 17.64% | 293.75% | ๐บ๐ธ USA |
Clovis Oncology CLVS | -163.43% | -3,747.99% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.